Prostate Cancer is a key topic under Science And Technology for UPSC Civil Services Examination. Key points include: Prostate cancer cases are projected to double globally by 2040, with LMICs like India facing the steepest rise.. India experiences a 65% mortality rate due to late-stage prostate cancer diagnosis.. Key risk factors include age (over 50), genetics, diet, obesity, smoking, and hormonal factors.. Understanding this topic is essential for both UPSC Prelims and Mains preparation.
Prostate Cancer is a Medium-level topic in UPSC Science And Technology. It is tested in both Prelims (factual MCQs) and Mains (analytical answer writing). Previous year UPSC questions have frequently covered aspects of Prostate Cancer, making it essential for comprehensive IAS preparation.
To prepare Prostate Cancer for UPSC: (1) Study the comprehensive notes covering all key concepts on Vaidra. (2) Practice previous year questions on this topic. (3) Connect it with current affairs using daily updates. (4) Revise using key takeaways and mind maps available for Science And Technology. (5) Write practice answers linking Prostate Cancer to related GS Paper topics.

A recent Lancet Commission paper has brought to light a concerning increase in prostate cancer cases across India. This surge is linked to a higher mortality rate, primarily due to diagnoses occurring at advanced stages of the disease.
In India, a significant 65% mortality rate is observed among prostate cancer patients, largely attributed to late-stage diagnosis.
Globally, prostate cancer cases are projected to double by 2040. Low and middle-income countries, including India, are expected to bear the brunt of this rise, with new cases in India potentially reaching 71,000 annually.
Prostate cancer is a form of cancer that originates in the prostate gland. This small gland is an integral part of the male reproductive system, situated just below the bladder.
The prostate gland's primary function is to produce fluid that is essential for nourishing and transporting sperm.
The Lancet Commission report forecasts a substantial global increase in prostate cancer cases, with the most significant rise anticipated in low and middle-income countries.
In 2020, prostate cancer was responsible for approximately 3,75,000 deaths worldwide, making it the fifth leading cause of cancer-related deaths in men.
Currently, it accounts for about 3% of all cancers in India, with an estimated 33,000 to 42,000 new cases diagnosed each year.
The global increase in ageing populations and enhanced life expectancy contributes to a larger demographic of older men, which inherently elevates the risk of developing prostate cancer.
Several factors are known to increase the risk of developing prostate cancer. Understanding these can aid in prevention and early detection strategies.
In its early stages, prostate cancer is often asymptomatic, meaning it shows no noticeable signs. However, as the disease progresses, various symptoms may emerge.
Early detection is critical, as symptoms often appear only in later stages when treatment may be more challenging.
The primary method for screening and detecting potential prostate cancer involves a specific blood test.
The Prostate-Specific Antigen (PSA) blood test measures the level of PSA in the blood. Elevated PSA levels can be an indicator of prostate cancer.
However, it's important to note that elevated PSA levels can also result from other conditions, such as an enlarged prostate (benign prostatic hyperplasia - BPH) or inflammation (prostatitis), not necessarily cancer.
For UPSC, understand that the PSA test is a screening tool, not a definitive diagnostic test. Further investigations are required for confirmation.
Treatment for prostate cancer varies depending on the stage of the cancer, the patient's overall health, and other factors. Common treatment modalities include:

